141 related articles for article (PubMed ID: 885471)
1. Pancreatic glucagon-like immunoreactivity in a pancreatectomized patient.
Botha JL; Vinik AI; Child PT; Paul M; Jackson WP
Horm Metab Res; 1977 May; 9(3):199-205. PubMed ID: 885471
[TBL] [Abstract][Full Text] [Related]
2. Absence of true pancreatic glucagon but persistence of circulating pancreatic glucagon-like immunoreactivity after pancreatectomy in pigs.
Holst JJ; Kreutzfeldt M; Holm G; Jensen E; Poulsen JS; Sparsö B; Sparsö B; Schmidt A
Diabete Metab; 1978 Jun; 4(2):75-9. PubMed ID: 680313
[TBL] [Abstract][Full Text] [Related]
3. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
[TBL] [Abstract][Full Text] [Related]
4. Effect of insulin on the response of gut glucagon-like immunoreactivity (GLI) to oral glucose and food ingestion in the goose.
Karmann H; Mialhe P
Horm Metab Res; 1987 Feb; 19(2):47-52. PubMed ID: 3549502
[TBL] [Abstract][Full Text] [Related]
5. Maximal stimulation of pancreatic islet B-cells, and A-cell response to arginine, in dogs with longterm pancreatic acinar atrophy.
Meister R; Berger I; Schwille PO; Gebhardt C
Eur J Surg; 1991 May; 157(5):333-40. PubMed ID: 1678647
[TBL] [Abstract][Full Text] [Related]
6. The peculiar processing of glucagon and glucagon-related peptides in patients after pancreatectomy.
Tanjoh K; Tomita R; Hayashi N
Hepatogastroenterology; 2002; 49(45):825-32. PubMed ID: 12064000
[TBL] [Abstract][Full Text] [Related]
7. Response of extrapancreatic immunoreactive glucagon to intraluminal nutrients in pancreatectomized dogs.
Ohneda A; Kobayashi T; Nihei J
Horm Metab Res; 1984 Jul; 16(7):344-8. PubMed ID: 6386643
[TBL] [Abstract][Full Text] [Related]
8. Elevation of plasma glucagon-like immunoreactivity (GLI) in patients with liver cirrhosis.
Watanabe A; Hashimoto M; Higashi T; Kobayashi M; Nakatsukasa H; Yamauchi Y; Watanabe M; Fujiwara M; Nagashima H
J Med; 1986; 17(2):95-108. PubMed ID: 3473162
[TBL] [Abstract][Full Text] [Related]
9. Peculiar glucagon processing in the intestine is the genesis of the paradoxical rise of serum pancreatic glucagon in patients after total pancreatectomy.
Tanjoh K; Tomita R; Fukuzawa M; Hayashi N
Hepatogastroenterology; 2003; 50(50):535-40. PubMed ID: 12749267
[TBL] [Abstract][Full Text] [Related]
10. Glucagon deficiency and hyperaminoacidemia after total pancreatectomy.
Boden G; Master RW; Rezvani I; Palmer JP; Lobe TE; Owen OE
J Clin Invest; 1980 Mar; 65(3):706-16. PubMed ID: 6986412
[TBL] [Abstract][Full Text] [Related]
11. Glucose, insulin and glucagon in the diabetic goose.
Karmann H; Mialhe P
Horm Metab Res; 1976 Nov; 8(6):419-26. PubMed ID: 1002101
[TBL] [Abstract][Full Text] [Related]
12. Contribution of partial pancreatectomy, systemic hormone delivery, and duct obliteration to glucose regulation in canine pancreas. Importance in pancreas transplantation.
van der Burg MP; Gooszen HG; Guicherit OR; Jansen JB; Frölich M; van Haastert FA; Lamers CB
Diabetes; 1989 Sep; 38(9):1082-9. PubMed ID: 2670640
[TBL] [Abstract][Full Text] [Related]
13. Purification of canine gut glucagon-like immunoreactivity (GLI) and its insulin releasing activity.
Ohneda A; Horigome K; Kai Y; Itabashi H; Ishii S; Yamagata S
Horm Metab Res; 1976 May; 8(3):170-4. PubMed ID: 939462
[TBL] [Abstract][Full Text] [Related]
14. Glucagon secretion in four duodenopancreatectomized patients after arginine and glucose load.
Krause U; Thiel M; Beyer J; Mangold G; Cordes U
Horm Metab Res; 1980 Aug; 12(8):364-9. PubMed ID: 7409739
[TBL] [Abstract][Full Text] [Related]
15. The effect of calcium and other salts upon the release of glucagon-like immunoreactivity from the gut.
Böttger I; Faloona GR; Unger RH
J Clin Invest; 1972 Apr; 51(4):831-6. PubMed ID: 5014613
[TBL] [Abstract][Full Text] [Related]
16. Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment.
Matsuyama T; Hoffman WH; Dunbar JC; Foà NL; Foà PP
Horm Metab Res; 1975 Nov; 7(6):452-6. PubMed ID: 1213649
[TBL] [Abstract][Full Text] [Related]
17. Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human.
Bringer J; Mirouze J; Marchal G; Pham TC; Luyckx A; Lefebvre P; Orsetti A
Diabetes; 1981 Oct; 30(10):851-6. PubMed ID: 6115786
[TBL] [Abstract][Full Text] [Related]
18. Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients.
Muller WA; Berger M; Suter P; Cüppers HJ; Reiter J; Wyss T; Berchtold P; Schmidt FH; Assal JP; Renold AE
J Clin Invest; 1979 May; 63(5):820-7. PubMed ID: 447830
[TBL] [Abstract][Full Text] [Related]
19. [Endocrine pancreas function in mucoviscidosis].
Knöpfle G
Klin Padiatr; 1985; 197(1):13-20. PubMed ID: 3883047
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic hormones and plasma glucose: regulation mechanisms in the goose under physiological conditions. I. Pancreatectomy and replacement therapy.
Sitbon G; Mialhe P
Horm Metab Res; 1978 Jan; 10(1):12-6. PubMed ID: 631734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
